Home › Products › Others › Combiklas Peri Injection
Combiklas Peri Injection
Salt Composition: DEXTROSE SOLUTION,AMINO ACID,INTRALIPID
- Manufacturer: ALNICHE LIFE SCIENCES PVT LTD
- Pack Size: 1 BOTTLE(s) OF 384ML
- Dosage Form: INJECTION
- Prescription Required
- Storage: Store at room temperature, between 15-25°C Keep away from moisture, heat, and light. It should not be frozen. Keep away from children and pets.
₹2145.00₹2681.25
Inclusive of all taxes
Product Introduction
Combiklas Peri Injection contains Dextrose solution, Amino acids, and Intralipid. It is a parenteral nutrition medication that provides nutritional support to patients unable to receive oral nutrition. Parenteral nutrition is necessary for patients with a malfunctioning gastrointestinal tract, including those with burns, trauma, sepsis, short gut syndrome, inflammatory bowel disease, tumours, or pancreatitis. It may also be used to provide additional nutrition before, during, and after surgery.
This medication provides nutritional support to patients unable to receive oral nutrition due to gastrointestinal tract disorders such as short gut syndrome, inflammatory bowel disease, tumours, pancreatitis, peritonitis, fistula, and ulcerative colitis. It is also used in critical illnesses including burns, trauma, sepsis, head injuries, and cachexia.
Patients with hypersensitivity to Dextrose solution, Amino acids, Intralipid, or any ingredients in this medication should not use it. This medication should not be used in uncorrected metabolic or electrolyte imbalances, acute liver and kidney failure, or active infection. Patients with severe fluid overload should also avoid this medication.
Combiklas Peri Injection should be used cautiously in older adults, as they are more likely to experience side effects such as infection, blood clots, and liver problems. This medication is not approved for use in patients under 18 years of age.
Uses
Combiklas Peri Injection is used in the following: Gastrointestinal tract disorders Critical illness Cancer Preoperative, perioperative, and postoperative support Additional nutrition for enteral nutrition patients
How it works
Combiklas Peri Injection is absorbed into the bloodstream through the vein where it is administered. The dextrose provides energy, the amino acids build and repair tissues, and the lipids provide essential fatty acids.
How to Use
Combiklas Peri Injection is administered intravenously, infusing it into a vein. It is typically administered through a central venous catheter (CVC). The choice of administration route may depend on the situation providing the medication.
Side Effects
Combiklas Peri Injection causes some side effects like all medications, although not everyone will experience them. Serious: Allergic reactions Blood clots Fluid overload Liver problems Kidney problems Sepsis Common: Fatigue Headache Nausea Vomiting Diarrhea Constipation Irritation at the infusion site Increased blood sugar levels Low blood potassium levels Low blood calcium levels Low blood magnesium levels
Expert Tips
Combiklas Peri Injection can cause blood sugar levels to rise, so it is important to monitor your blood sugar levels closely while taking this medication. It can put extra strain on the heart, so monitoring your heart function closely while taking this medication is important. If you have a severe allergic reaction to any of the ingredients in this medication, you should seek immediate medical attention. This medication can worsen metabolic or electrolyte imbalances, so it is important to have these imbalances corrected. It is important to avoid this medication if you have severe fluid overload.
References
- Alniche Life Sciences Pvt. Ltd., [Revised on 2021][Accessed on 28th September 2023], https://www.alniche.com/product/combiklas/
- Baxter Healthcare Corporation, US Food and Drug Administration, [Revised on May 2022] [Accessed on 28th September 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/017643s072,018449s039lbl.pdf
- Corey Resnick, Nutritional Protocol for the Treatment of Intestinal Permeability Defects and Related Conditions, Natural Medicine Journal, 2010, 2(3), https://www.naturalmedicinejournal.com/print/61
- Jeffery W. Spray, Review of Intravenous Lipid Emulsion Therapy, Journal of Infusion Nursing, 2016, 39(6), https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102272/pdf/jinfn-39-377.pdf
Safety Advice
Pregnancy: Consult your doctor There is not enough reliable information to know if Combiklas Peri Injection is safe to take during pregnancy or breastfeeding. Therefore, you must talk to your doctor before taking this medication if you are pregnant.
Lungs: Consult your doctor Combiklas Peri Injection has not been specifically studied in patients with lung disease. However, you must consult your healthcare provider before taking this medication if you have lung disease.
Breastfeeding: Consult your doctor Combiklas Peri Injection should only be used during breastfeeding if the potential benefits outweigh the potential risks. Always consult a healthcare provider before taking this medication while breastfeeding.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.